3.26
price down icon8.94%   -0.32
after-market Handel nachbörslich: 3.28 0.02 +0.61%
loading

Finanzdaten der Anixa Biosciences Inc-Aktie (ANIX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- 0.21 - -
Research and Development
14.82%
1.322
1.552 1.476 1.925 1.646
Costs And Expenses
11.31%
3.003
3.386 3.163 3.592 3.467
Operating Income/Loss
11.31%
-3.003
-3.386 -3.163 -3.592 -3.467
Income/Loss From Continuing Operations Before Tax
12.45%
-2.813
-3.213 -2.913 -3.315 -3.18
Income/Loss From Continuing Operations After Tax
12.45%
-2.813
-3.213 -2.913 -3.315 -3.18
Net Income/Loss
12.45%
-2.813
-3.213 -2.913 -3.315 -3.18
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
20.69%
-0.023
-0.029 -0.03 -0.038 -0.041
Basic Average Shares
0.02%
32.20
32.20 0.000094 0.0321 0.0319
Diluted Average Shares
0.02%
32.20
32.20 0.000094 0.0321 0.0319
Basic Earnings Per Share
10.00%
-0.09
-0.10 -0.09 -0.10 -0.10
Diluted Earnings Per Share
10.00%
-0.09
-0.10 -0.09 -0.10 -0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$38.53
price up icon 0.36%
$98.64
price up icon 3.39%
$31.57
price up icon 0.83%
$93.81
price down icon 1.05%
biotechnology ONC
$310.67
price down icon 2.63%
$196.92
price down icon 0.05%
Kapitalisierung:     |  Volumen (24h):